Role of TLR9 in Oncogenic Virus-Produced Cancer.
Nucleic acid recognition by toll-like receptor 9 (TLR9) initiates signaling pathways that regulate the production of proinflammatory cytokines or type I interferons, as well as many other molecules required to initialize the immune response. The use of synthetic oligodeoxynucleotides (ODNs) has been crucial to emulate the recognition of DNA sequences by TLR9. Furthermore, ODN administration to mice has shown to confer protection against a wide range of viral, bacterial, and parasitic pathogens. In contrast, oncogenic DNA viruses like hepatitis B virus, Epstein-Barr virus, and human papilloma virus inhibit TLR9 expression, thus contributing to the establishment of chronic viral infections. In this review, we will focus on TLR9 signals initiated by ODN recognition, on the inhibition of TLR9 expression mediated by DNA oncogenic viruses, and on TLR9 expression as a relevant event in the progression to cancer, considering other functions of this receptor, aside from viral recognition.
Dirección de Infecciones Crónicas y Cáncer, Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca , Morelos, Mexico .
Cecilia
C
Martínez-Campos
Dirección de Infecciones Crónicas y Cáncer, Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca , Morelos, Mexico .
Ana I
AI
Burguete-García
Dirección de Infecciones Crónicas y Cáncer, Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca , Morelos, Mexico .
Vicente
V
Madrid-Marina
D000818:Animals; D063646:Carcinogenesis; D054884:Host-Pathogen Interactions; D006801:Humans; D009369:Neoplasms / Q000503:physiopathology* / Q000821:virology*; D009858:Oncogenic Viruses / Q000472:pathogenicity*; D051217:Toll-Like Receptor 9 / Q000378:metabolism*
D051217:Toll-Like Receptor 9
TLR9; cancer; oncogenic virus